When does the $20 billion authorization take effect?

The reauthorized program begins in the third quarter of 2026. The firm separately repurchased $1.5 billion in the second quarter under its prior program.

How many shares did Morgan Stanley repurchase in Q2 2026?

Morgan Stanley repurchased 8 million shares at an average price of $197.64 per share, totaling $1.5 billion. This reduced period-end common shares outstanding from 1,598 million to 1,572 million.

What execution mechanism will be used for the buyback?

The filing does not specify whether repurchases will occur under Rule 10b-18 open-market purchases, an accelerated share repurchase, or another mechanism. Standard practice at Morgan Stanley is open-market execution under 10b-18.

Does the $20 billion authorization have an expiration date?

No. The Board reauthorized the program 'without a set expiration date,' giving management ongoing discretion to execute repurchases at its discretion without a preset deadline.

How does this buyback compare to Morgan Stanley's prior authorizations?

The filing does not disclose the amount or terms of the previous authorization that was being replaced. The $20 billion represents the new authorized amount effective from Q3 2026 onward.

Did Morgan Stanley increase its dividend alongside the buyback authorization?

Yes. The Board declared a quarterly dividend of $1.15 per share, an increase of $0.15 per share. The dividend is payable August 14, 2026, representing another form of shareholder capital return.

MS-PQ 8-K Filed 2026-07-15 New authorization

Morgan Stanley authorizes $20B share repurchase program

Board reauthorized multi-year buyback with no set expiration; Q2 execution included $1.5B repurchase

Authorization$20.0B

MechanismNot specified

What the filing says

Morgan Stanley's Board of Directors reauthorized a multi-year common equity share repurchase program of up to $20 billion without a set expiration date, effective in the third quarter of 2026. This announcement comes on the heels of strong second-quarter earnings, with the firm posting record net revenues of $21.3 billion and earnings per diluted share of $3.46.

During the second quarter ended June 30, 2026, Morgan Stanley repurchased $1.5 billion of its outstanding common stock under the existing Share Repurchase Program. The firm repurchased 8 million shares at an average price of $197.64 per share, reducing period-end common shares outstanding from 1,598 million to 1,572 million shares.

The authorization covers repurchases of common stock with no specified execution mechanism disclosed in this filing. The $20 billion program represents a significant authorization for returning capital to shareholders alongside the firm's recently increased quarterly dividend of $1.15 per share, an increase of 15 cents.

The Board of Directors reauthorized a multi-year common equity share repurchase program of up to $20 billion, without a set expiration date, beginning in the third quarter of 2026. — MORGAN STANLEY 8-K filing · View on SEC EDGAR →

What this means

The $20 billion reauthorization reflects Morgan Stanley's capital management strategy after achieving strong profitability and maintaining robust regulatory capital ratios. The firm's Standardized Common Equity Tier 1 ratio stood at 14.8% in Q2 2026, providing flexibility for shareholder returns. The Q2 repurchase of 8 million shares at $197.64 per share reduced the share count by roughly 0.5% during the quarter. Without a set expiration date, the authorization allows management discretion over timing and execution, decoupled from market cycles or preset deadlines.

Frequently asked questions

When does the $20 billion authorization take effect?: The reauthorized program begins in the third quarter of 2026. The firm separately repurchased $1.5 billion in the second quarter under its prior program.
How many shares did Morgan Stanley repurchase in Q2 2026?: Morgan Stanley repurchased 8 million shares at an average price of $197.64 per share, totaling $1.5 billion. This reduced period-end common shares outstanding from 1,598 million to 1,572 million.
What execution mechanism will be used for the buyback?: The filing does not specify whether repurchases will occur under Rule 10b-18 open-market purchases, an accelerated share repurchase, or another mechanism. Standard practice at Morgan Stanley is open-market execution under 10b-18.
Does the $20 billion authorization have an expiration date?: No. The Board reauthorized the program 'without a set expiration date,' giving management ongoing discretion to execute repurchases at its discretion without a preset deadline.
How does this buyback compare to Morgan Stanley's prior authorizations?: The filing does not disclose the amount or terms of the previous authorization that was being replaced. The $20 billion represents the new authorized amount effective from Q3 2026 onward.
Did Morgan Stanley increase its dividend alongside the buyback authorization?: Yes. The Board declared a quarterly dividend of $1.15 per share, an increase of $0.15 per share. The dividend is payable August 14, 2026, representing another form of shareholder capital return.

authorization mega-cap financial-services 2026 multi-year no-expiration

Source. This editorial summary is based on the SEC filing linked above. BuybackStocks aggregates and editorializes publicly available SEC EDGAR filings. Not investment advice. Past authorization announcements do not guarantee future repurchase activity or share price performance. See our full disclosures policy.